These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 7352783)
21. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?]. Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for survival in malignant melanoma of the eyelid skin. Esmaeli B; Wang B; Deavers M; Gillenwater A; Goepfert H; Diaz E; Eicher S Ophthalmic Plast Reconstr Surg; 2000 Jul; 16(4):250-7. PubMed ID: 10923972 [TBL] [Abstract][Full Text] [Related]
24. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Morton DL; Wanek L; Nizze JA; Elashoff RM; Wong JH Ann Surg; 1991 Oct; 214(4):491-9; discussion 499-501. PubMed ID: 1953101 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589 [TBL] [Abstract][Full Text] [Related]
33. Cutaneous melanoma of the head and neck. Vreeburg GC; Schouwenburg PF; Hilgers FJ; de Kraker NW; Hart AA Eur J Surg Oncol; 1988 Apr; 14(2):165-70. PubMed ID: 3360158 [TBL] [Abstract][Full Text] [Related]
34. The debate over immediate lymph node dissection in melanoma. Goldsmith HS Surg Gynecol Obstet; 1979 Mar; 148(3):403-5. PubMed ID: 419443 [TBL] [Abstract][Full Text] [Related]
35. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Breslow A Ann Surg; 1975 Nov; 182(5):572-5. PubMed ID: 1190862 [TBL] [Abstract][Full Text] [Related]
36. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients. Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514 [TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
38. Regional lymph node dissections in malignant melanoma. Lawton GP; Ariyan S Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563 [TBL] [Abstract][Full Text] [Related]
39. [Preventive lymph node excision in the treatment concept of melanoma of the extremities]. Binder J; Henneking K Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334 [TBL] [Abstract][Full Text] [Related]
40. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity]. Huber R; Krüger I; Stützer H Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]